This chemical is widely used in the development of bioconjugates, particularly in drug delivery systems. It serves as a linker molecule that connects therapeutic agents to targeting molecules, enhancing the specificity and efficiency of drug delivery. Its PEG (polyethylene glycol) moiety improves solubility and reduces immunogenicity, making it suitable for creating biocompatible and stable conjugates. Additionally, it is employed in the synthesis of peptide-based drugs and antibody-drug conjugates (ADCs), where it helps maintain the stability and activity of the active pharmaceutical ingredients. Its lipoamide group also facilitates interactions with cellular membranes, aiding in the intracellular delivery of therapeutic agents.